Revenue Growth of 9.5%, Currency Neutral Growth of 8.5%Q4 Annual Subscriber Revenue Growth of 11.8%Annual Subscriber Revenue Represents 54.9% ...
Announced sale of FibroGen China to AstraZeneca for a total consideration of approximately $160 millionTransaction expected to close by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback